skip to main content
Mostrar Somente
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Metastatic angiosarcomas (mAS): Identification of treatments that significantly improve the outcome
Material Type:
Artigo
Adicionar ao Meu Espaço

Metastatic angiosarcomas (mAS): Identification of treatments that significantly improve the outcome

Amela, E. ; Italiano, A. ; Ray-Coquard, I. L. ; Chaigneau, L. ; Delcambre, C. ; Bui Nguyen, B. ; Bertucci, F. ; Isambert, N. ; Cupissol, D. ; Bompas, E. ; Bay, J. ; Duffaud, F. ; Guillemet, C. ; Corradini, N. ; Cassier, P. A. ; Chevreau, C. ; Blay, J. ; Penel, N.

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.10085-10085 [Periódico revisado por pares]

Texto completo disponível

2
Elderly patients with aggressive non-Hodgkin's lymphoma: disease presentation, response to treatment, and survival--a Groupe d'Etude des Lymphomes de l'Adulte study on 453 patients older than 69 years
Material Type:
Artigo
Adicionar ao Meu Espaço

Elderly patients with aggressive non-Hodgkin's lymphoma: disease presentation, response to treatment, and survival--a Groupe d'Etude des Lymphomes de l'Adulte study on 453 patients older than 69 years

BASTION, Y ; BLAY, J.-Y ; SALLES, B ; DUMONTET, C ; BRIERE, J ; COIFFIER, B ; DIVINE, M ; BRICE, P ; BORDESSOULE, D ; SEBBAN, C ; BLANC, M ; TILLY, H ; LEDERLIN, P ; DECONINCK, E

Journal of clinical oncology, 1997-08, Vol.15 (8), p.2945-2953 [Periódico revisado por pares]

Baltimore, MD: American Society of Clinical Oncology

Sem texto completo

3
Prognostic factors for progression-free and overall survival in patients with advanced GIST treated with standard-dose imatinib (IM): Results from the BFR14 phase III trial of the French Sarcoma Group
Material Type:
Artigo
Adicionar ao Meu Espaço

Prognostic factors for progression-free and overall survival in patients with advanced GIST treated with standard-dose imatinib (IM): Results from the BFR14 phase III trial of the French Sarcoma Group

Bertucci, F. ; Blay, J. ; Ray-Coquard, I. L. ; Bui Nguyen, B. ; Adenis, A. ; Rios, M. ; Duffaud, F. ; Cupissol, D. ; Chevreau, C. ; Bompas, E. ; Cioffi, A. ; Nehal, L. ; Perol, D. ; Le Cesne, A.

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.e20506-e20506 [Periódico revisado por pares]

Texto completo disponível

4
Outcome of patients (pts) with PDGFRA D842V mutant gastrointestinal stromal tumor (GIST) treated with imatinib (IM) for advanced disease
Material Type:
Artigo
Adicionar ao Meu Espaço

Outcome of patients (pts) with PDGFRA D842V mutant gastrointestinal stromal tumor (GIST) treated with imatinib (IM) for advanced disease

Biron, P. ; Cassier, P. A. ; Fumagalli, E. ; Blesius, A. ; Debiec-Rychter, M. ; Adenis, A. ; Verweij, J. ; Hohenberger, P. ; Blay, J. ; Casali, P. G.

Journal of clinical oncology, 2010-05, Vol.28 (15_suppl), p.10051-10051 [Periódico revisado por pares]

Texto completo disponível

5
ELYPSE 2: A prospective randomized trial comparing filgrastim (G-CSF) in primary and secondary prophylaxis in patients (pts) at high risk for febrile neutropenia (FN)
Material Type:
Artigo
Adicionar ao Meu Espaço

ELYPSE 2: A prospective randomized trial comparing filgrastim (G-CSF) in primary and secondary prophylaxis in patients (pts) at high risk for febrile neutropenia (FN)

Biron, P. ; Ray-Coquard, I. ; Le Cesne, A. ; Dussart, S. ; Goilliot, C. ; Bachelot, T. ; Thyss, A. ; Gilles, E. ; Chabaud, S. ; Blay, J.

Journal of clinical oncology, 2006-06, Vol.24 (18_suppl), p.8614-8614 [Periódico revisado por pares]

Sem texto completo

6
Denosumab safety and efficacy in giant cell tumor of bone (GCTB): Interim results from a phase II study
Material Type:
Artigo
Adicionar ao Meu Espaço

Denosumab safety and efficacy in giant cell tumor of bone (GCTB): Interim results from a phase II study

Blay, J. ; Chawla, S. P. ; Martin Broto, J. ; Choy, E. ; Dominkus, M. ; Engellau, J. ; Grimer, R. ; Henshaw, R. M. ; Palmerini, E. ; Reichardt, P. ; Rutkowski, P. ; Skubitz, K. M. ; Thomas, D. M. ; Zhao, Y. ; Qian, Y. ; Jacobs, I. A.

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.10034-10034 [Periódico revisado por pares]

Texto completo disponível

7
High-dose methotrexate for the treatment of primary cerebral lymphomas: analysis of survival and late neurologic toxicity in a retrospective series
Material Type:
Artigo
Adicionar ao Meu Espaço

High-dose methotrexate for the treatment of primary cerebral lymphomas: analysis of survival and late neurologic toxicity in a retrospective series

BLAY, J.-Y ; CONROY, T ; DRAMAIS-MARCEL, D ; BAUMELOU, E ; CHAUVIN, F ; BIRON, P ; CHEVREAU, C ; THYSS, A ; QUESNEL, N ; EGHBALI, H ; BOUABDALLAH, R ; COIFFIER, B ; WAGNER, J.-P ; LE MEVEL, A

Journal of clinical oncology, 1998-03, Vol.16 (3), p.864-871 [Periódico revisado por pares]

Baltimore, MD: American Society of Clinical Oncology

Sem texto completo

8
ELYPSE-7: A randomized, placebo-controlled, phase 2a study evaluating the impact of IL-7 on CD4 count, hematological toxicity, and tumor progressionin metastatic breast cancer (MBC) patients (pts)
Material Type:
Artigo
Adicionar ao Meu Espaço

ELYPSE-7: A randomized, placebo-controlled, phase 2a study evaluating the impact of IL-7 on CD4 count, hematological toxicity, and tumor progressionin metastatic breast cancer (MBC) patients (pts)

Blay, Jean-Yves ; Tredan, Olivier ; Menetrier-Caux, Christine ; Cropet, Claire ; Bachelot, Thomas Denis ; Heudel, Pierre ; Rebattu, Paul E. ; Garin, Gwenaelle ; Chabaud, Sylvie ; Verronese, Estelle ; Cadore, Anne Claire ; Fouillat, Valerie ; Croughs, Therese ; Morre, Michel ; Clapisson, Gilles ; Caux, Christophe ; Pérol, David ; Ray-Coquard, Isabelle Laure

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.3033-3033 [Periódico revisado por pares]

Texto completo disponível

9
Outcome of 157 adult rhabdomyosarcoma (RMS) patients: A retrospective study from the French Group Sarcoma (GSF-GETO)
Material Type:
Artigo
Adicionar ao Meu Espaço

Outcome of 157 adult rhabdomyosarcoma (RMS) patients: A retrospective study from the French Group Sarcoma (GSF-GETO)

Bompas, E. ; Campion, L. ; Italiano, A. ; Cesne, A. l. ; Giaj Levra, M. ; Chevreau, C. ; Piperno-Neumann, S. ; Isambert, N. ; Thyss, A. ; Rios, M. ; Kurtz, J. ; Delcambre, C. ; Bay, J. ; Duffaud, F. ; Trassard, M. ; Soulie, P. ; Blay, J.

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.10070-10070 [Periódico revisado por pares]

Texto completo disponível

10
Development and validation of a prediction model for early death among cancer patients participating in phase I clinical trials of new cytotoxic agents
Material Type:
Artigo
Adicionar ao Meu Espaço

Development and validation of a prediction model for early death among cancer patients participating in phase I clinical trials of new cytotoxic agents

Bonneterre, M. E. ; Penel, N. ; Bachelot, T. ; Pascal, L. ; Blay, J. Y. ; Delord, J. ; Adenis, A. ; Bonneterre, J.

Journal of clinical oncology, 2008-05, Vol.26 (15_suppl), p.2537-2537 [Periódico revisado por pares]

Texto completo disponível

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Recursos Online (36)

Buscando em bases de dados remotas. Favor aguardar.